Related Experiment Videos
Increase plasma viscosity sustains microcirculation after resuscitation from hemorrhagic shock and continuous
Pedro Cabrales1, Marcos Intaglietta, Amy G Tsai
1La Jolla Bioengineering Institute, La Jolla, California 92093-0412, USA. pcabrales@ucsd.edu
Shock (Augusta, Ga.)
|May 18, 2005
Summary
Hyperviscous plasma expanders improved resuscitation outcomes in hemorrhagic shock models. Enhanced viscosity sustained blood pressure and microvascular flow, offering a longer treatment window for severe blood loss.
Area of Science:
- Physiology
- Biomedical Engineering
- Emergency Medicine
Background:
- Hemorrhagic shock, a life-threatening condition, requires rapid and effective resuscitation.
- Conventional plasma expanders may have limitations in sustaining microvascular function post-resuscitation.
- Optimizing resuscitation strategies is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of hyperviscous plasma expanders in a hamster model of severe hemorrhagic shock.
- To compare the effects of different viscosity levels of hydroxyethyl starch (HES) and alginate mixtures on resuscitation outcomes.
- To investigate the impact of viscosity on microvascular flow and arterial blood pressure maintenance.
Main Methods:
- A 50% blood volume hemorrhage model was established in unanesthetized hamsters, followed by continuous bleeding.
- Resuscitation was performed using hydroxyethyl starch (HES) solutions with varying alginate concentrations to achieve different viscosities.
- Hemodynamic parameters, microvascular flow, and capillary perfusion were monitored over 90 minutes post-resuscitation.
Main Results:
- All tested solutions initially improved hemodynamic parameters post-resuscitation.
- Viscosity-enhanced solutions demonstrated superior and sustained improvements in arterial blood pressure, microvascular flow, and capillary perfusion compared to low-viscosity solutions.
- Low-viscosity resuscitation led to a return of microvascular parameters to shock levels by 90 minutes.
Conclusions:
- Hyperviscous plasma expanders can prolong the therapeutic window for managing severe blood loss by preserving microcirculation.
- Enhanced viscosity appears to improve blood flow by maintaining shear stress and reducing peripheral vascular resistance.
- These findings suggest potential for developing advanced hyperviscous plasma expanders for critical care settings.